Cartesian Therapeutics (RNAC) Operating Margin (QoQ) (2015 - 2026)

Cartesian Therapeutics (RNAC) Operating Margin (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cartesian Therapeutics 226.07 Mn 226.07 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.57 Mn
Mar 31, 2025 -518,740.00
Jun 30, 2024 26,991.00
Mar 31, 2024 21,097.00
Dec 31, 2023 -24,010.00
Sep 30, 2023 15,564.00
Jun 30, 2023 -4,553.00
Mar 31, 2023 -25,896.00
Dec 31, 2022 -4,287.00
Sep 30, 2022 -4,301.00
Jun 30, 2022 361.00
Mar 31, 2022 1,806.00
Dec 31, 2021 2,168.00
Sep 30, 2021 -1,036.00
Jun 30, 2021 6,708.00
Mar 31, 2021 131.00
Dec 31, 2020 22,952.00
Jun 30, 2019 -632,462.00
Mar 31, 2019 -11.70 Mn
Dec 31, 2017 -6.21 Mn